Stockscreener 앱 받기
0.8285
0.18%
0.0015
시장 영업 전:
.83
0.0015
+0.18%
전일 마감가:
$0.827
열려 있는:
$0.851
하루 거래량:
527.92K
Relative Volume:
1.16
시가총액:
$10.54M
수익:
-
순이익/손실:
$-22.76M
주가수익비율:
-0.0903
EPS:
-9.1712
순현금흐름:
$-27.90M
1주 성능:
-55.70%
1개월 성능:
-81.21%
6개월 성능:
-85.96%
1년 성능:
-96.33%
1일 변동 폭
$0.8004
$0.851
1주일 범위
$0.6697
$0.9435
52주 변동 폭
$0.6697
$23.40
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
명칭
Reviva Pharmaceuticals Holdings Inc
전화
(408) 501-8881
주소
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.8285 | 10.54M | 0 | -22.76M | -27.90M | -9.1712 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-05 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2025-09-29 | 개시 | Chardan Capital Markets | Buy |
| 2023-09-20 | 개시 | ROTH MKM | Buy |
| 2023-06-08 | 개시 | The Benchmark Company | Speculative Buy |
| 2022-01-24 | 개시 | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc 주식(RVPH)의 최신 뉴스
Analysts Remain Confident in Reviva Pharmaceuticals Holdings (RVPH) Amid 1-for-20 Reverse Stock Split - Insider Monkey
CVI/Heights disclose 666,667 shares (5.2%) in Reviva Pharmaceuticals (NASDAQ: RVPH) - Stock Titan
Aug Mood: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant stock outperform in a bear marketWeekly Stock Analysis & Safe Investment Capital Preservation Plans - baoquankhu1.vn
If You Invested $1,000 in Reviva Pharmaceutcls Hldgs Inc (RVPH) - Stock Titan
Parag Saxena reports Reviva (RVPH) stake at 2.8%, below 5% level - Stock Titan
Reviva Pharmaceuticals raises $10 million in public offering By Investing.com - Investing.com Canada
Reviva Pharmaceuticals raises $10 million in public offering - Investing.com
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering - The Manila Times
Reviva says $10M raise funds schizophrenia trial into Q1 2027 - Stock Titan
What's behind the drop in Reviva Pharmaceuticals stock? - MSN
Aug Levels: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant benefit from deglobalization2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Wall Street Recap: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant being accumulated by smart moneyM&A Rumor & High Win Rate Trade Alerts - baoquankhu1.vn
Reviva Pharmaceuticals Announces $10 Million Equity Offering - The Globe and Mail
Reviva (NASDAQ: RVPH) CFO granted 40,925 stock options under 2020 plan - Stock Titan
Reviva (RVPH) CEO receives 150,075 stock option grants under 2020 plan - Stock Titan
Reviva Pharmaceuticals Holdings Announces Securities Purchase Agreement and New Warrants Offering March 2026 - Minichart
Reviva Pharmaceuticals (NASDAQ: RVPH) raises equity with detachable warrants and pre‑funded options - Stock Titan
Reviva (NASDAQ: RVPH) prices $10M equity deal to fund Phase 3 trial - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
What's Behind The Drop In Reviva Pharmaceuticals Stock? - Benzinga
Dow Falls Over 300 Points; US Initial Jobless Claims Fall - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
$10M raise backs Reviva's Phase 3 schizophrenia drug trial - Stock Titan
Gold Tumbles Over 6%; Accenture Earnings Top Views - Sahm
Reviva Pharmaceuticals prices $10M public offering at $1.50 By Investing.com - Investing.com India
Reviva Pharmaceuticals announces public stock and warrant offering By Investing.com - Investing.com South Africa
Why Did RVPH Stock Crash 40% In Pre-Market Today? - Stocktwits
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - GlobeNewswire
Reviva Pharmaceuticals prices $10M public offering at $1.50 - Investing.com
Reviva Pharmaceuticals announces pricing of $10 million public offering at $1.50 per share - marketscreener.com
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - Benzinga
Reviva Pharmaceuticals announces public stock and warrant offering - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Reviva Pharmaceuticals (NASDAQ: RVPH) proposes sale of stock, warrants to fund Phase 3 - Stock Titan
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewswire
Press Release: Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - Moomoo
Gainers Report: Is now the right time to enter Reviva Pharmaceuticals Holdings IncQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Setup Watch: Should I hold or sell Conduit Pharmaceuticals Inc now2026 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Value Recap: What makes Reviva Pharmaceuticals Holdings Inc stock attractive todayGDP Growth & AI Based Trade Execution Alerts - baoquankhu1.vn
Breakout Watch: How correlated is Reviva Pharmaceuticals Holdings Inc to the S P5002026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Volume Summary: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentInflation Watch & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 - Investing.com Nigeria
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold By Investing.com - Investing.com Nigeria
Reviva Pharmaceuticals Holdings Inc NPV Share Price - Hargreaves Lansdown
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears - TechStock²
HC Wainwright & Co. Maintains Reviva Pharmaceuticals Holdings (RVPH) Buy Recommendation - MSN
US Market Wrap: Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Reviva Pharmaceuticals Announces Major Share Consolidation Plan - AD HOC NEWS
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reacts to inflationary pressures2025 Pullback Review & Weekly High Potential Stock Alerts - Naître et grandir
CEO Moves: Is now the right time to enter Reviva Pharmaceuticals Holdings Inc2025 Market WrapUp & Risk Controlled Swing Alerts - baoquankhu1.vn
Reviva Pharmaceuticals Holdings Inc (RVPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):